Minimal Residual Disease in Acute Lymphoblastic Leukemia
- 1 January 2009
- journal article
- research article
- Published by Elsevier in Seminars in Hematology
- Vol. 46 (1) , 100-106
- https://doi.org/10.1053/j.seminhematol.2008.09.001
Abstract
No abstract availableThis publication has 74 references indexed in Scilit:
- Status of minimal residual disease testing in childhood haematological malignanciesBritish Journal of Haematology, 2008
- Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group studyBlood, 2008
- Quantitative analysis of minimal residual disease predicts relapse in children with B-lineage acute lymphoblastic leukemia in DFCI ALL Consortium Protocol 95-01Blood, 2007
- A set of genes that regulate cell proliferation predicts treatment outcome in childhood acute lymphoblastic leukemiaBlood, 2007
- Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR dataLeukemia, 2007
- Genes contributing to minimal residual disease in childhood acute lymphoblastic leukemia: prognostic significance of CASP8AP2Blood, 2006
- Concurrent detection of minimal residual disease (MRD) in childhood acute lymphoblastic leukaemia by flow cytometry and real‐time PCRBritish Journal of Haematology, 2005
- Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lymphoblastic leukemiaBlood, 2002
- Detection of minimal residual disease in acute leukemia by flow cytometryCytometry, 1999
- Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhoodThe Lancet, 1998